These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 943577

  • 1. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
    Skinner DG, Dekernion JB, Brower PA, Ramming KP, Pilch YH.
    J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
    [Abstract] [Full Text] [Related]

  • 2. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA, Dekernion JB, Ramming KP.
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Richie JP, Wang BS, Steele GD, Wilson RE, Mannick JA.
    J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
    [Abstract] [Full Text] [Related]

  • 4. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
    Ramming KP, deKernion JB.
    Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
    [Abstract] [Full Text] [Related]

  • 5. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
    Steele G, Wang BS, Richie J, Wilson RE, Ervin T, Yankee R, Fallon M, Mannick JA.
    Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
    [No Abstract] [Full Text] [Related]

  • 6. Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.
    Richie JP, Steele GD, Wilson RE, Ervin T, Wang BS, Mannick JA.
    J Urol; 1984 Feb; 131(2):236-8. PubMed ID: 6199519
    [Abstract] [Full Text] [Related]

  • 7. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL, Kern DH, Pilch YH.
    Am J Obstet Gynecol; 1974 Aug 01; 119(7):959-65. PubMed ID: 4135321
    [No Abstract] [Full Text] [Related]

  • 8. Re: in vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Bander NH.
    J Urol; 1982 Apr 01; 127(4):783. PubMed ID: 6175772
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The therapy of renal adenocarcinoma with immune RNA.
    deKernion JB, Ramming KP.
    Invest Urol; 1980 Mar 01; 17(5):378-81. PubMed ID: 7358501
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid.
    deKernion JB, Ramming KP, Brower P, Skinner DG, Pilch YH.
    Am J Surg; 1975 Nov 01; 130(5):575-8. PubMed ID: 1200271
    [No Abstract] [Full Text] [Related]

  • 12. Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma.
    Steele G, Wang BS, Richie JP, Ervin T, Yankee R, Mannick JA.
    Cancer; 1981 Mar 15; 47(6):1286-8. PubMed ID: 6164471
    [Abstract] [Full Text] [Related]

  • 13. Aggressive versus conservative management of stage IV renal cell carcinoma.
    Klugo RC, Detmers M, Stiles RE, Talley RW, Cerny JC.
    J Urol; 1977 Aug 15; 118(2):244-6. PubMed ID: 894800
    [Abstract] [Full Text] [Related]

  • 14. Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.
    Fritze D, Kern DH, Pilch YH.
    Klin Wochenschr; 1976 Sep 15; 54(18):851-63. PubMed ID: 787654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunological response to tumor ischemia in a murine renal cell carcinoma model.
    Edson Pontes J, Goldrosen M, Murphy GP.
    Oncology; 1983 Sep 15; 40(1):63-6. PubMed ID: 6823406
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy of renal cell carcinoma.
    deKernion JB.
    Prog Clin Biol Res; 1984 Sep 15; 153():409-21. PubMed ID: 6206509
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypernephroma with xenogeneic immune RNA.
    deKernion JB, Ramming KP.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):347-9. PubMed ID: 748792
    [Abstract] [Full Text] [Related]

  • 19. Immune ribonucleic acid (I-RNA) in the treatment of metastatic renal cell carcinoma.
    De Vinci C, Pizza G, Severini G, Cuzzocrea D, Corrado F.
    J Exp Pathol; 1987 Dec 15; 3(4):515-23. PubMed ID: 2457666
    [No Abstract] [Full Text] [Related]

  • 20. Experimental and clinical studies on toxicity of xenogeneic tumor-specific immune ribonucleic acid.
    Fukushima M, Fukuda S, Machida S, Ishikawa Y.
    Tohoku J Exp Med; 1979 Jul 15; 128(3):285-93. PubMed ID: 494251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.